Companies: 10,795·Total market cap: $144.5T
Pyxis Oncology, Inc.

Pyxis Oncology, Inc.

PYXSNASDAQHealthcare● Active
$1.69
$-0.09(-5.06%)
Market Cap$107070761
P/E Ratio
52W High$5.55
52W Low$0.97
Overview

Pyxis Oncology, Inc. (PYXS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · PYXS · as of Mar 23, 2026

Latest filing snapshot

55
+11+25.00%vs prior year

Pyxis Oncology, Inc. (PYXS) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
55
Change (1Y)
+11
Growth % (1Y)
+25.00%
Revenue / Employee
$252.0K
Net Income / Employee
$-1.45M
Market Cap
$107M

PYXS Employee Count

2021 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-2355+11+25.00%
2025-03-1844-6-12.00%
2024-03-2150-25-33.33%
2023-03-2275+19+33.93%
2022-03-2956

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Humacyte, Inc.
HUMA
Humacyte, Inc.
218
#2
Caribou Biosciences, Inc.
CRBU
Caribou Biosciences, Inc.
147
#3
Enanta Pharmaceuticals, Inc.
ENTA
Enanta Pharmaceuticals, Inc.
131
#4
Foghorn Therapeutics Inc.
FHTX
Foghorn Therapeutics Inc.
112
#5
Atea Pharmaceuticals, Inc.
AVIR
Atea Pharmaceuticals, Inc.
56
#6
Pyxis Oncology, Inc.
PYXS
Pyxis Oncology, Inc.YOU
55
#7
Immuneering Corporation
IMRX
Immuneering Corporation
54
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · PYXS peer comparison

About PYXS employees

PYXS Employees · Headcount

Pyxis Oncology, Inc. (PYXS) employee data is sourced from the annual SEC 10-K filing. As of 2025, Pyxis Oncology, Inc. had 55 full-time employees globally. Full-time employees only. Global consolidated headcount.

Pyxis Oncology, Inc. employs 55 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $251,964, reflecting the company's operational efficiency.

Pyxis Oncology, Inc.'s workforce increased by 11 (25.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Pyxis Oncology, Inc.'s revenue per employee of $251,964 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

PYXS Employees · 5 questions

As of the latest SEC 10-K filing (2025), Pyxis Oncology, Inc. had 55 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Pyxis Oncology, Inc. employee counthow many employees does Pyxis Oncology, Inc. havePYXS total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-23